×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
KTTA – pasithea therapeutics corp. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
KTTA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/20
07:05 am
ktta
Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer [Yahoo! Finance]
High
Report
Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer [Yahoo! Finance]
11/20
07:02 am
ktta
Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer
Low
Report
Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer
10/7
04:54 pm
ktta
Pasithea Therapeutics files to sell 3.74M shares of common stock for holders [Seeking Alpha]
Medium
Report
Pasithea Therapeutics files to sell 3.74M shares of common stock for holders [Seeking Alpha]
9/26
06:44 pm
ktta
Pasithea Therapeutics Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Medium
Report
Pasithea Therapeutics Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
9/26
07:08 am
ktta
Pasithea Therapeutics Announces Positive Initial Safety, Tolerability, Pharmacokinetic (PK), and Preliminary Efficacy Data from its Phase 1 Clinical Trial of PAS-004 in Advanced Cancer [Yahoo! Finance]
High
Report
Pasithea Therapeutics Announces Positive Initial Safety, Tolerability, Pharmacokinetic (PK), and Preliminary Efficacy Data from its Phase 1 Clinical Trial of PAS-004 in Advanced Cancer [Yahoo! Finance]
9/26
07:02 am
ktta
Pasithea Therapeutics Announces Positive Initial Safety, Tolerability, Pharmacokinetic (PK), and Preliminary Efficacy Data from its Phase 1 Clinical Trial of PAS-004 in Advanced Cancer
High
Report
Pasithea Therapeutics Announces Positive Initial Safety, Tolerability, Pharmacokinetic (PK), and Preliminary Efficacy Data from its Phase 1 Clinical Trial of PAS-004 in Advanced Cancer
9/9
08:19 am
ktta
Pasithea Therapeutics Announces Successful Completion of PAS-004 Chronic Toxicity Studies [Yahoo! Finance]
Neutral
Report
Pasithea Therapeutics Announces Successful Completion of PAS-004 Chronic Toxicity Studies [Yahoo! Finance]
9/9
08:01 am
ktta
Pasithea Therapeutics Announces Successful Completion of PAS-004 Chronic Toxicity Studies
Low
Report
Pasithea Therapeutics Announces Successful Completion of PAS-004 Chronic Toxicity Studies
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
03:33 pm
ktta
Form SC 13G Pasithea Therapeutics Filed by: ARMISTICE CAPITAL, LLC
Neutral
Report
Form SC 13G Pasithea Therapeutics Filed by: ARMISTICE CAPITAL, LLC
11/13
04:31 pm
ktta
Form 10-Q Pasithea Therapeutics For: Sep 30
Medium
Report
Form 10-Q Pasithea Therapeutics For: Sep 30
10/15
06:12 am
ktta
Form EFFECT Pasithea Therapeutics
High
Report
Form EFFECT Pasithea Therapeutics
10/11
05:13 pm
ktta
Form 424B3 Pasithea Therapeutics
Low
Report
Form 424B3 Pasithea Therapeutics
10/7
04:45 pm
ktta
Form S-3 Pasithea Therapeutics
Medium
Report
Form S-3 Pasithea Therapeutics
9/30
04:50 pm
ktta
Form 8-K Pasithea Therapeutics For: Sep 26
High
Report
Form 8-K Pasithea Therapeutics For: Sep 26
9/26
08:45 am
ktta
Form 8-K Pasithea Therapeutics For: Sep 26
High
Report
Form 8-K Pasithea Therapeutics For: Sep 26
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: